Unclaimed brand
Convergent Genomics is on a mission to simplify and accelerate cancer diagnostics serving clinicians and patients with personalized data.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#1CABCC
Java
28, 171, 204
191, 76, 45
86, 16, 0, 20
#82C0C7
Half Baked
130, 192, 199
186, 38, 65
35, 4, 0, 22
#222222
Mine Shaft
34, 34, 34
0, 0, 13
0, 0, 0, 87
Convergent Genomics is a brand dedicated to simplifying and expediting cancer diagnostics for clinicians and patients through personalized data. They are focused on revolutionizing cancer care by utilizing comprehensive genomic profiling of urine DNA to detect cancer risks at a genetic level earlier. With their expertise in liquid biopsy and next-generation sequencing, Convergent Genomics can identify emerging cancer cells years before traditional testing methods.
Their groundbreaking non-invasive genomic urine test, UroAmp, provides accurate and quantifiable prognostic and predictive data that can change the timeline for cancer detection. By offering a whole new perspective on cancer diagnosis, Convergent Genomics is empowering clinicians to make informed treatment choices and improving outcomes for patients. Founded by a team of cancer biologists, urologic oncologists, and data scientists, Convergent Genomics is committed to advancing cancer care and revolutionizing bladder cancer diagnosis through their innovative approach
Company type
Privately Held
Year founded
2015
Company size
11-50 employees
The Convergent Genomics name, logos and brand assets are trademarks of Convergent Genomics and its affiliates. Brandfetch isn't affiliated with or endorsed by Convergent Genomics. Their use is subject to Convergent Genomics's brand guidelines.
